Uganda vs Zambia: HIV/AIDS deaths averted by antiretroviral therapy
Uganda
82,921 deaths
in 2024
Zambia
76,693 deaths
in 2024
Uganda rank
6th
Zambia rank
7th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Uganda
- Zambia
How they compare
Uganda currently reports 82,921 deaths against 76,693 deaths in Zambia, a difference of 6,228 deaths.
That makes Uganda's figure about 1.1 times Zambia's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Zambia ahead.
Uganda ranks 6th and Zambia ranks 7th of 157 countries.
Across the 4 decades both report, Uganda averaged higher in 2 and Zambia in 1.
Head to head by decade
| Decade | Uganda | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 12,859 deaths | 13,774 deaths | 914.83 deaths | Zambia |
| 2010s | 56,072 deaths | 53,855 deaths | 2,217 deaths | Uganda |
| 2020s | 81,329 deaths | 72,723 deaths | 8,606 deaths | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Uganda or Zambia?
- Uganda, at 82,921 deaths against 76,693 deaths in Zambia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Uganda and Zambia?
- 6,228 deaths, with Uganda ahead.
- How many years of comparable data are there for Uganda and Zambia?
- 35 years are reported by both, from 1990 to 2024.
- How do Uganda and Zambia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Uganda ranks 6th and Zambia ranks 7th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.